• Product NameStugeron
• Brief DescriptionInhibitors
• Purification99.00%
• Biological ActivityCinnarizine is a drug derivative of piperazine, and characterized as an antihistamine and a calcium channel blocker, it is also known to promote cerebral blood flow, and so is used to treat cerebral apoplexy, post-trauma cerebral symptoms, and cerebral arteriosclerosis.
• Target NameCalcium Channel inhibitor; Histamine Receptor antagonist
• CAS No. 298-57-7
• Calculated MW 368.51
• Formulation C26H28N2
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cardiovascular System
  SMILES:C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4
  Pathways:GPCR/G Protein; Membrane transporter/Ion channel; Immunology/Inflammation; Neuroscience
  Receptor:Calcium Channel; H1 receptor
  Boling pt:509.2C
  Melting pt:117-120C
  Solubility:Soluble in DMSO
  Appearance:White Crystal
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Terland O, et al. Neuropharmacology. 1999 Jun;38(6):879-82.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting